Clinical Trial Update: Phase 2 Study of TLK286 in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of TLK286 for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TLK286

Snippet

Sponsor: Telik | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED